← FDA Drug Approvals (Drugs@FDA)

DEXILANT

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2009-01-30

Drug application

FDA Application #

NDA022287

Application type

New Drug Application

Brand name

DEXILANT

Generic name

DEXLANSOPRAZOLE

Active ingredients

DEXLANSOPRAZOLE

Dosage form

CAPSULE, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2009-01-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown